iNOS Activation Regulates β-catenin Association with Its Partners in Endothelial Cells

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Gonzalez, Deyarina ^a   Rojas, Armando ^b   Herrera, Maria Beatriz ^c   Conlan, R Steven ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSIDAD CATÓLICA DEL MAULE   (Chile)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEIN P120; SYNAPTOTAGMIN I; T CELL FACTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL VIABILITY; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INDUCTION; GENE EXPRESSION; MACROPHAGE ACTIVATION; MOUSE; NITRATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TRANSPORT;

ANIMALS; BETA CATENIN; CELL SURVIVAL; CELLS, CULTURED; CYTOSKELETAL PROTEINS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL;

ANIMALIA; MURINAE;

EID: 84871697248     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052964     Document Type: Article

References (54)

1. Kibbe M, Billiar T, Tzeng E, (1999) Inducible nitric oxide synthase and vascular injury. Cardiovasc Res 43(3): 650-657.
2. Kanwar JR, Kanwar RK, Burrow H, Baratchi S, (2009) Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr Med Chem 16(19): 2373-2394.
3. Rojas A, Gonzalez D, Figueroa H, Morales MA, Romero J, (2010) Modulation of Nitric Oxide Pathway by Multiligands/RAGE Axis: A Crossing Point on the Road to Microvascular Complication in Diabetes Current Enzyme Inhibition. 6(1): 34-45.
4. Monteiro HP, Rocha Oliveira CJ, Curcio MF, Moraes MS, Arai RJ, (2005) Tyrosine phosphorylation in nitric oxide-mediated signaling events. Methods Enzymol 396: 350-8.
5. Gow AJ, Farkouh CR, Munson DA, Posencheg MA, Ischiropoulos H, (2004) Biological significance of nitric oxide-mediated protein modifications. Am J Physiol Lung Cell Mol Physiol. 287(2): L262-8.
6. Illi B, Colussi C, Grasselli A, Farsetti A, Capogrossi MC, et al. (2009) NO sparks off chromatin: Tales of a multifaceted epigenetic regulator. Pharmacol Ther 123(3): 344-352.
7. Williams JL, Ji P, Ouyang N, Kopelovich L, Rigas B, (2011) Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action. Exp Cell Res. 317(10): 1359-1367.
8. Knepler JL Jr, Taher LN, Gupta MP, Patterson C, Pavalko F, et al. (2001) Peroxynitrite causes endothelial cell monolayer barrier dysfunction. Am J Physiol Cell Physiol 281(3): C1064-1075.
9. Prevotat L, Filomenko R, Solary E, Jeannin J-F, Bettaieb A, (2006) Nitric Oxide-Induced Down-Regulation of [beta]-Catenin in Colon Cancer Cells by a Proteasome-Independent Specific Pathway. Gastroenterology 131(4): 1142-1152.
10. Navarro P, Caveda L, Breviario F, Mândoteanu I, Lampugnani M-G, et al. (1995) Catenin-dependent and-independent Functions of Vascular Endothelial Cadherin. J Biol Chem 270(52): 30965-30972.
11. MacDonald BT, Tamai K, He X, (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17(1): 9-26.
12. Deng J, Miller SA, Wang H-Y, Xia W, Wen Y, et al. (2002) [beta]-catenin interacts with and inhibits NF-[kappa]B in human colon and breast cancer. Cancer Cell 2(4): 323-334.
13. Xie QW, Kashiwabara Y, Nathan C, (1994) Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269(7): 4705-4708.
14. Harris TJ, Peifer M, (2005) Decisions, decisions: beta-catenin chooses between adhesion and transcription Trends Cell Biol. 15(5): 234-7.
15. Lilien J, Balsamo J, (2005) The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of [beta]-catenin. Curr Opin Cell Biol 17(5): 459-465.
16. Beckers CM, García-Vallejo JJ, van Hinsbergh VW, van Nieuw Amerongen GP, (2008) Nuclear targeting of beta-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction. Cardiovasc Res 79(4): 679-88.
17. Weis SM, Cheresh DA, (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437(7058): 497-504.
18. Nath N, Kashfi K, Chen J, Rigas B, (2003) Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin-TCF association. Proc Natl Acad Sci U S A 100(22): 12584-12589.
19. Nath N, Labaze G, Rigas B, Kashfi K, (2005) NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates [beta]-catenin expression. Biochem Biophys Res Commun 326(1): 93-99.
20. Gonzalez D, Herrera B, Beltran A, Otero K, Quintero G, et al. (2003) Nitric oxide disrupts VE-cadherin complex in murine microvascular endothelial cells. Biochem Biophys Res Commun 304(1): 113-118.
21. MacMicking J, Xie QW, Nathan C, (1997) Nitric oxide and macrophage function. Annu Rev Immunol. 15: 323-50.
22. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, et al. (1994) Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A 91(6): 2046-50.
23. Nathan C, Xie QW, (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78(6): 915-8.
24. Balligand JL, Ungureanu-Longrois D, Simmons WW, Kobzik L, Lowenstein CJ, et al. (1995) Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma. Am J Physiol Heart Circ Physiol 268(3): H1293-1303.
25. Dighiero P, Behar-Cohen F, Courtois Y, Goureau O, (1997) Expression of inducible nitric oxide synthase in bovine corneal endothelial cells and keratocytes in vitro after lipopolysaccharide and cytokines stimulation. Invest Ophthalmol Vis Sci 38(10): 2045-2052.
26. Palmer RM, Rees DD, Ashton DS, Moncada S, (1988) L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 153(3): 1251-6.
27. Wallez Y, Huber P, (2008) Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 1778(3): 794-809.
28. Piedra J, Martinez D, Castano J, Miravet S, Dunach M, et al. (2001) Regulation of beta-Catenin Structure and Activity by Tyrosine Phosphorylation. J Biol Chem 276(23): 20436-20443.
29. Van Veelen W, Le HN, Helvensteijn W, Blonden L, Theeuwes M, et al. (2011) β-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis. Gut 60: 1204-1212.
30. Udahayakumar G, Jaynthi V, Devaraj N, Devaraj H, (2011) Nuclear translocation of β-catenin correlates with CD44 upregulation in Helicobacter pilori-infected gastric carcinoma. Mol Cell Biochem 357 (1-2): 283-293.
31. Krikos A, Laherty CD, Dixit VM, (1992) Transcriptional activation of tumor necrosis factor alpha-inducible zinc finger protein A20, is mediated by kappa B elements. J. Biol.Chem 267: 17971-17976.
32. Chang K, Lee SJ, Cheong I, Billiar TR, Chung HT, et al. (2004) Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post-translational modification of IkappaB. Exp Mol Med 36(4): 311-324.
33. Hubert P, Dalmon J, Engiles J, Brevario F, Gory S, et al. (1996) Genomic structure and chromosomal mapping of the mouse VE-cadherin gene (Cdh5). Genomics 32: 21-28.
34. Prandini MH, Dreher I, Bouillot S, Benkerri S, Moll T, et al. (2005) The human VE-cadherin promoter is subjected to organ specific regulation and is activated in tumour angiogenesis Oncogene 24. (18): 2992-3001.
35. Lin J, Guan Z, Wang C, Feng L, Zheng Y, et al. (2010) Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res 16(1): 77-87.
36. Zhu H, Zhang G, Wang Y, Xu N, He S, et al. (2010) Inhibition of ErbB2 by Herceptin reduces survivin expression via the ErbB2-beta catenin/TCF4- survivin pathway in ErbB2-overexpressed breats cancer cells. Cancer Sci 101: 1156-1162.
37. Andriopoulou P, Navarro P, Zanetti A, Lampugnani MG, Dejana E, (1999) Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherents junctions. Arterioscler Thromb Vasc Biol 19: 2286-2297.
38. Risau W, (1997) Mechanism of angiogenesis. Nature 386: 671-674.
39. Kimura H, Weisz A, Kurashima Y, Ogura T, D'Acquisto F, et al. (2000) Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95: 189-97.
40. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W, (1998) Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci. 111 (Pt 13): 1853-65.
41. Hatanaka K, Simons M, Murakami M, (2011) Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. Am J Physiol Heart Circ Physiol. 300(1): H162-72.
42. Dejana E, Tournier-Lasserve E, Weinstein BM, (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell. 16(2): 209-21.
43. Thoreson MA, Anastasiadis PZ, Daniel JM, Ireton RC, Wheelock MJ, et al. (2000) Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion. J Cell Biol.148 (1): 189-202.
44. Alemà S, Salvatore AM, (2007) p120 catenin and phosphorylation: Mechanisms and traits of an unresolved issue. Biochim Biophys Acta 1773(1): 47-58.
45. Mariner DJ, Davis MA, Reynolds AB, (2004) EGFR signaling to p120-catenin through phosphorylation at Y228. J Cell Sci.117 (Pt 8): 1339-50.
46. Xiao K, Garner J, Buckley KM, Vincent PA, Chiasson CM, et al. (2005) p120-Catenin regulates clathrin dependent endocytosis of VE-cadherin. Mol Biol Cell 16: 5141-5151.
47. Pacher P, Beckman JS, Liaudet L, (2007) Nitric Oxide and Peroxynitrite in health and disease. Physiol Rev 87: 315-424.
48. Du Q, Zhang X, Cardinal J, Cao Z, Guo Z, et al. (2009) Wnt/β-catenin Signaling Regulates Cytokine-Induced Human Inducible Nitric Oxide Synthase Expression by Inhibiting Nuclear Factor-{kappa}B Activation in Cancer Cells. Cancer Res 69(9): 3764-3771.
49. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, et al. (2002) A Role for the β-Catenin/T-Cell Factor Signaling Cascade in Vascular Remodeling. Circ Res 90(3): 340-347.
50. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, et al. (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10(8): 923-934.
51. Wright M, Aikawa M, Szeto W, Papkoff J, (1999) Identification of a Wnt-Responsive Signal Transduction Pathway in Primary Endothelial Cells. Biochem Biophys Res Commun. 263(2): 384-388.
52. Garlanda C, Parravicini C, Sironi M, De Rossi M, Wainstok de Calmanovici R, et al. (1994) Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors. Proc Natl Acad Sci U S A 91(15): 7291-7295.
53. Otero K, Martinez F, Beltran A, Gonzalez D, Herrera B, et al. (2001) Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem J 359(3): 567-574.
54. Gonzalez D, Drapier JC, Bouton C, (2004) Endogenous nitration of iron regulatory protein-1 (IRP-1) in nitric oxide-producing murine macrophages: further insight into the mechanism of nitration in vivo and its impact on IRP-1 functions. J Biol Chem. 279(41): 43345-51.